139 related articles for article (PubMed ID: 25562121)
1. Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1.
Almeida L; Oliveira J; Guimarães LH; Carvalho EM; Blackwell JM; Castellucci L
Infect Genet Evol; 2015 Mar; 30():225-229. PubMed ID: 25562121
[TBL] [Abstract][Full Text] [Related]
2. Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil.
Castellucci L; Jamieson SE; Almeida L; Oliveira J; Guimarães LH; Lessa M; Fakiola M; Jesus AR; Nancy Miller E; Carvalho EM; Blackwell JM
Infect Genet Evol; 2012 Jul; 12(5):1102-10. PubMed ID: 22554650
[TBL] [Abstract][Full Text] [Related]
3. FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil.
Castellucci L; Jamieson SE; Miller EN; de Almeida LF; Oliveira J; Magalhães A; Guimarães LH; Lessa M; Lago E; de Jesus AR; Carvalho EM; Blackwell JM
Genes Immun; 2011 Oct; 12(7):589-94. PubMed ID: 21633373
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expression of FLI1 and MMP1 in American cutaneous leishmaniasis caused by Leishmania braziliensis infection.
Almeida L; Silva JA; Andrade VM; Machado P; Jamieson SE; Carvalho EM; Blackwell JM; Castellucci LC
Infect Genet Evol; 2017 Apr; 49():212-220. PubMed ID: 28119029
[TBL] [Abstract][Full Text] [Related]
5. The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.
Ramasawmy R; Menezes E; Magalhães A; Oliveira J; Castellucci L; Almeida R; Rosa ME; Guimarães LH; Lessa M; Noronha E; Wilson ME; Jamieson SE; Kalil J; Blackwell JM; Carvalho EM; de Jesus AR
Infect Genet Evol; 2010 Jul; 10(5):607-13. PubMed ID: 20430117
[TBL] [Abstract][Full Text] [Related]
6. CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.
Castellucci L; Jamieson SE; Miller EN; Menezes E; Oliveira J; Magalhães A; Guimarães LH; Lessa M; de Jesus AR; Carvalho EM; Blackwell JM
BMC Med Genet; 2010 Jan; 11():10. PubMed ID: 20089160
[TBL] [Abstract][Full Text] [Related]
7. FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis.
da Hora AS; de Almeida LF; do Lago TS; Machado PR; Castellucci LC
Mem Inst Oswaldo Cruz; 2020; 115():e190361. PubMed ID: 32130370
[TBL] [Abstract][Full Text] [Related]
8. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
[TBL] [Abstract][Full Text] [Related]
9. The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated With Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by
Lago TS; Silva JA; Lago EL; Carvalho EM; Zanette DL; Castellucci LC
Front Immunol; 2018; 9():2621. PubMed ID: 30487794
[No Abstract] [Full Text] [Related]
10. Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil.
de Araújo Santos FJ; da Silva LS; Júnior JDES; Ramos de Mesquita TG; de Souza MLG; de Andrade Júnior MC; Talhari S; Ramasawmy R
PLoS One; 2019; 14(8):e0220572. PubMed ID: 31393896
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil.
de Araujo FJ; da Silva LD; Mesquita TG; Pinheiro SK; Vital Wde S; Chrusciak-Talhari A; Guerra JA; Talhari S; Ramasawmy R
PLoS Negl Trop Dis; 2015; 9(6):e0003875. PubMed ID: 26107286
[TBL] [Abstract][Full Text] [Related]
12. Functional variations in MBL2 gene are associated with cutaneous leishmaniasis in the Amazonas state of Brazil.
de Araujo FJ; Mesquita TG; da Silva LD; de Almeida SA; de S Vital W; Chrusciak-Talhari A; de O Guerra JA; Talhari S; Ramasawmy R
Genes Immun; 2015 Jun; 16(4):284-8. PubMed ID: 25764115
[TBL] [Abstract][Full Text] [Related]
13. IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.
Castellucci L; Menezes E; Oliveira J; Magalhaes A; Guimaraes LH; Lessa M; Ribeiro S; Reale J; Noronha EF; Wilson ME; Duggal P; Beaty TH; Jeronimo S; Jamieson SE; Bales A; Blackwell JM; de Jesus AR; Carvalho EM
J Infect Dis; 2006 Aug; 194(4):519-27. PubMed ID: 16845637
[TBL] [Abstract][Full Text] [Related]
14. The wound repair response controls outcome to cutaneous leishmaniasis.
Sakthianandeswaren A; Elso CM; Simpson K; Curtis JM; Kumar B; Speed TP; Handman E; Foote SJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15551-6. PubMed ID: 16223880
[TBL] [Abstract][Full Text] [Related]
15. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.
Blackwell JM; Black GF; Peacock CS; Miller EN; Sibthorpe D; Gnananandha D; Shaw JJ; Silveira F; Lins-Lainson Z; Ramos F; Collins A; Shaw MA
Philos Trans R Soc Lond B Biol Sci; 1997 Sep; 352(1359):1331-45. PubMed ID: 9355125
[TBL] [Abstract][Full Text] [Related]
16. Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing.
Sakthianandeswaren A; Curtis JM; Elso C; Kumar B; Baldwin TM; Lopaticki S; Kedzierski L; Smyth GK; Foote SJ; Handman E
Infect Immun; 2010 Jun; 78(6):2734-44. PubMed ID: 20368343
[TBL] [Abstract][Full Text] [Related]
17. Candidate gene case-control and functional study shows macrophage inhibitory factor (MIF) polymorphism is associated with cutaneous leishmaniasis.
de Jesus Fernandes Covas C; Cardoso CC; Gomes-Silva A; Santos Oliveira JR; Da-Cruz AM; Moraes MO
Cytokine; 2013 Jan; 61(1):168-72. PubMed ID: 23068083
[TBL] [Abstract][Full Text] [Related]
18. Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil.
Castellucci LC; Almeida LF; Jamieson SE; Fakiola M; Carvalho EM; Blackwell JM
Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):279-88. PubMed ID: 24863979
[TBL] [Abstract][Full Text] [Related]
19. Genetic Polymorphisms of
Gorący I; Grudniewicz S; Safranow K; Ciechanowicz A; Jakubiszyn P; Gorący A; Brykczyński M
Dis Markers; 2020; 2020():9567239. PubMed ID: 33029260
[TBL] [Abstract][Full Text] [Related]
20. Consolidation of a Molecular Signature of Healing in Cutaneous Leishmaniasis Is Achieved during the First 10 Days of Treatment.
Giraldo-Parra L; Rebellón-Sánchez DE; Navas A; Belew AT; El-Sayed NM; Gómez MA
J Immunol; 2024 Mar; 212(5):894-903. PubMed ID: 38231122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
